ArticleGastrointestinal endoscopy clinics of North America2009
Targeted endoscopic imaging.
Article in Gastrointestinal endoscopy clinics of North America, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- Multicolor fluorescence imaging using a single RGB-IR CMOS sensor for cancer detection with smURFP-labeled probiotics.Biomedical optics express · 2020Article
- Imaging Inflammation and Infection in the Gastrointestinal Tract.International journal of molecular sciences · 2019Review
- A CD44-specific peptide, RP-1, exhibits capacities of assisting diagnosis and predicting prognosis of gastric cancer.Oncotarget · 2017Article
- Imaging of Mucosal Inflammation: Current Technological Developments, Clinical Implications, and Future Perspectives.Frontiers in immunology · 2017Review
- Advanced gastrointestinal endoscopic imaging for inflammatory bowel diseases.World journal of gastroenterology · 2016Review
- From the surface to the single cell: Novel endoscopic approaches in inflammatory bowel disease.World journal of gastroenterology · 2015Review
- Intravital imaging of mouse colonic adenoma using MMP-based molecular probes with multi-channel fluorescence endoscopy.Biomedical optics express · 2014Article
- Target-to-background enhancement in multispectral endoscopy with background autofluorescence mitigation for quantitative molecular imaging.Journal of biomedical optics · 2014Article
- Molecular imaging in gastroenterology.Nature reviews. Gastroenterology & hepatology · 2013Review
- Optical molecular imaging for diagnosing intestinal diseases.Clinical endoscopy · 2013Review
- Color-matched and fluorescence-labeled esophagus phantom and its applications.Journal of biomedical optics · 2013Article
- Recent advances in targeted endoscopic imaging: Early detection of gastrointestinal neoplasms.World journal of gastrointestinal endoscopy · 2012Article
- Future and advances in endoscopy.Journal of biophotonics · 2011Review
- Affinity peptide for targeted detection of dysplasia in Barrett's esophagus.Gastroenterology · 2010Article
- [Molecular imaging of the small intestine].Der Internist · 2010Article
- Molecular imaging in gastrointestinal endoscopy.Gastroenterology · 2010Review
- Molecular endoscopic imaging: the future is bright.Therapeutic advances in gastrointestinal endoscopyReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Endoscopy has undergone explosive technological growth in recent years, and with the emergence of targeted imaging, its truly transformative power and impact on medicine lies just over the horizon. Today, our ability to see inside the digestive tract with medical endoscopy is headed toward exciting crossroads. The existing paradigm of making diagnostic decisions based on observing structural changes and identifying anatomic landmarks may soon be replaced by visualizing functional properties and imaging molecular expression. In this novel approach, the presence of intracellular and cell surface targets unique to disease are identified and used to predict the likelihood of mucosal transformation and response to therapy. This strategy could result in the development of new methods for early cancer detection, personalized therapy, and chemoprevention. This targeted approach will require further development of molecular probes and endoscopic instruments, and will need support from the US Food and Drug Administration for streamlined regulatory oversight. Overall, this molecular imaging modality promises to significantly broaden the capabilities of the gastroenterologist by providing a new approach to visualize the mucosa of the digestive tract in a manner that has never been seen before.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.